Cargando…

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

BACKGROUND: Immune checkpoint inhibition, combined with novel biomarkers, may provide alternative pathways for treating chemotherapy-resistant triple-negative breast cancer (TNBC). This study investigates the expression of new immune checkpoint receptors, including CD155 and CD73, which play a role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabioglu, Neslihan, Bayram, Aysel, Emiroglu, Selman, Onder, Semen, Karatay, Huseyin, Oner, Gizem, Tukenmez, Mustafa, Muslumanoglu, Mahmut, Igci, Abdullah, Aydiner, Adnan, Saip, Pinar, Yavuz, Ekrem, Ozmen, Vahit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10374450/ https://www.ncbi.nlm.nih.gov/pubmed/37519808 http://dx.doi.org/10.3389/fonc.2023.1165257

Ejemplares similares

TIM3 expression on TILs is associated with poor response to neoadjuvant chemotherapy in patients with locally advanced triple-negative breast cancer
por: Cabioglu, Neslihan, et al.
Publicado: (2021)

Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
por: Oner, Gizem, et al.
Publicado: (2021)

Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
por: Oner, Gizem, et al.
Publicado: (2023)

Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
por: Emiroglu, Selman, et al.
Publicado: (2023)

High co-expression of immune checkpoint receptors PD-1, CTLA-4, LAG-3, TIM-3, and TIGIT on tumor-infiltrating lymphocytes in early-stage breast cancer
por: Mollavelioglu, Baran, et al.
Publicado: (2022)

Favorable Outcome with Close Margins in Patients Undergoing Nipple/Skin Sparing Mastectomy with Immediate Breast Reconstruction: 5-year Follow-up
por: Özkurt, Enver, et al.
Publicado: (2018)

Ozone therapy as a novel complementary therapeutic approach in refractory idiopathic granulomatous mastitis
por: Cabioglu, Neslihan, et al.
Publicado: (2023)

Breast cancer risk factors in Turkish women – a University Hospital based nested case control study
por: Ozmen, Vahit, et al.
Publicado: (2009)

Single axillary incision endoscopic surgery and liposuction for gynecomastia
por: Tukenmez, Mustafa, et al.
Publicado: (2023)

Is the thymidine labeling index a good prognostic marker in breast cancer?
por: Sen-Oran, Ebru, et al.
Publicado: (2007)

Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment
por: Aydiner, Adnan, et al.
Publicado: (2015)

Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy
por: Cabioglu, Neslihan, et al.
Publicado: (2023)

Comparison between body composition parameters and response to neoadjuvant chemotherapy by using pre-treatment PET CT in locally advanced breast cancer
por: Kizildag Yirgin, Inci, et al.
Publicado: (2020)

The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014)

Poor Biological Factors and Prognosis of Interval Breast Cancers: Long-Term Results of Bahçeşehir (Istanbul) Breast Cancer Screening Project in Turkey
por: Cabioğlu, Neslihan, et al.
Publicado: (2020)

Diagnostic Performance of AI for Cancers Registered in A Mammography Screening Program: A Retrospective Analysis
por: Kizildag Yirgin, Inci, et al.
Publicado: (2022)

The Clinical Significance of CD73 in Cancer
por: Bach, Niklas, et al.
Publicado: (2023)

Defining the CD39/CD73 Axis in SARS-CoV-2 Infection: The CD73(-) Phenotype Identifies Polyfunctional Cytotoxic Lymphocytes
por: Ahmadi, Parimah, et al.
Publicado: (2020)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73
Publicado: (1995)

CD28 engagement inhibits CD73-mediated regulatory activity of CD8(+) T cells
por: Lai, Yo-Ping, et al.
Publicado: (2021)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

CD73 Promotes Chronic Lymphocytic Leukemia
por: Allard, David, et al.
Publicado: (2022)

CD73: Friend or Foe in Lung Injury
por: Hu, Xiu-Min, et al.
Publicado: (2023)

Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
por: Crooke, Almudena, et al.
Publicado: (2017)

Monitoring and characterizing soluble and membrane-bound ectonucleotidases CD73 and CD39
por: Goueli, Said A., et al.
Publicado: (2019)

CD39 and CD73 as Promising Therapeutic Targets: What Could Be the Limitations?
por: Battastini, Ana Maria Oliveira, et al.
Publicado: (2021)

Ecto-5′-Nucleotidase (CD73) Regulates the Survival of CD8+ T Cells
por: Rosemblatt, Mariana V., et al.
Publicado: (2021)

CD39/CD73/A2AR pathway and cancer immunotherapy
por: Xia, Chenglai, et al.
Publicado: (2023)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Exploring CD39 and CD73 Expression as Potential Biomarkers in Prostate Cancer
por: Gardani, Carla Fernanda Furtado, et al.
Publicado: (2023)

Increased Soluble CD155 in the Serum of Cancer Patients
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2016)

CD155, an onco‐immunologic molecule in human tumors
por: Gao, Jian, et al.
Publicado: (2017)

CD155 and Its Receptors as Targets for Cancer Therapy
por: Paolini, Rossella, et al.
Publicado: (2023)

Comparison of Pathological Prognostic Stage and Anatomic Stage Groups According to the Updated Version of the American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8(th) Edition
por: Ibis, Kamuran, et al.
Publicado: (2018)

Increased CD112 Expression in Methylcholanthrene-Induced Tumors in CD155-Deficient Mice
por: Nagumo, Yoko, et al.
Publicado: (2014)

High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
por: Aliagas, Elisabet, et al.
Publicado: (2014)

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014)

Physiological roles for ecto-5’-nucleotidase (CD73)
por: Colgan, Sean P., et al.
Publicado: (2006)

Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_a8svvae2sftlcjve3fq94jebt3